Hamidreza Jamaati
Hamidreza Jamaati
Verified email at
Cited by
Cited by
Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries
G Bellani, JG Laffey, T Pham, E Fan, L Brochard, A Esteban, L Gattinoni, ...
Jama 315 (8), 788-800, 2016
Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study
JG Laffey, G Bellani, T Pham, E Fan, F Madotto, EK Bajwa, L Brochard, ...
Intensive care medicine 42, 1865-1876, 2016
Stress and burnout in health care workers during COVID-19 pandemic: validation of a questionnaire
N Talaee, M Varahram, H Jamaati, A Salimi, M Attarchi, ...
Journal of Public Health, 1-6, 2020
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series
SMR Hashemian, R Aliannejad, M Zarrabi, M Soleimani, M Vosough, ...
Stem cell research & therapy 12, 1-12, 2021
Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries
T Abe, F Madotto, T Pham, I Nagata, M Uchida, N Tamiya, K Kurahashi, ...
Critical care 22, 1-16, 2018
Anti-inflammatory effects of lactobacillus rahmnosus and bifidobacterium breve on cigarette smoke activated human macrophages
E Mortaz, IM Adcock, FLM Ricciardolo, M Varahram, H Jamaati, ...
PLoS One 10 (8), e0136455, 2015
Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study
JG Laffey, F Madotto, G Bellani, T Pham, E Fan, L Brochard, P Amin, ...
The Lancet Respiratory Medicine 5 (8), 627-638, 2017
Nitric oxide in the pathogenesis and treatment of tuberculosis
H Jamaati, E Mortaz, Z Pajouhi, G Folkerts, M Movassaghi, ...
Frontiers in microbiology 8, 2008, 2017
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
P Tabarsi, S Barati, H Jamaati, S Haseli, M Marjani, A Moniri, Z Abtahian, ...
International immunopharmacology 90, 107205, 2021
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial
H Jamaati, SMR Hashemian, B Farzanegan, M Malekmohammad, ...
European journal of pharmacology 897, 173947, 2021
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial
F Dastan, SA Nadji, A Saffaei, M Marjani, A Moniri, H Jamaati, ...
International immunopharmacology 85, 106688, 2020
Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis
MV Maddali, M Churpek, T Pham, E Rezoagli, H Zhuo, W Zhao, J He, ...
The Lancet Respiratory Medicine 10 (4), 367-377, 2022
Increased serum levels of soluble TNF-α receptor is associated with ICU mortality in COVID-19 patients
E Mortaz, P Tabarsi, H Jamaati, N Dalil Roofchayee, NK Dezfuli, ...
Frontiers in Immunology 12, 592727, 2021
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study
T Pham, L Heunks, G Bellani, F Madotto, I Aragao, G Beduneau, ...
The Lancet Respiratory Medicine 11 (5), 465-476, 2023
Effect of the Cardio First Angel™ device on CPR indices: a randomized controlled clinical trial
A Vahedian-Azimi, M Hajiesmaeili, A Amirsavadkouhi, H Jamaati, M Izadi, ...
Critical Care 20, 1-8, 2016
Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study
F Madotto, T Pham, G Bellani, LD Bos, FD Simonis, E Fan, A Artigas, ...
Intensive care medicine 44, 564-577, 2018
Promising effects of tocilizumab in COVID-19: a non-controlled, prospective clinical trial
F Dastan, A Saffaei, S Haseli, M Marjani, A Moniri, Z Abtahian, A Abedini, ...
International immunopharmacology 88, 106869, 2020
COVID-19: molecular and cellular response
SD Alipoor, E Mortaz, H Jamaati, P Tabarsi, H Bayram, M Varahram, ...
Frontiers in cellular and infection microbiology 11, 563085, 2021
A fourteen-day experience with coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS): an Iranian treatment protocol
H Jamaati, F Dastan, P Tabarsi, M Marjani, A Saffaei, SMR Hashemian
Iranian Journal of Pharmaceutical Research: IJPR 19 (1), 31, 2020
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
SMR Hashemian, N Shafigh, G Afzal, H Jamaati, P Tabarsi, M Marjani, ...
Pulmonology 27 (6), 486-492, 2021
The system can't perform the operation now. Try again later.
Articles 1–20